Evaluating tetrahydrocannabinol as an adjunct to opioid agonist therapy for individuals living with opioid use disorder: A Phase II, placebo-controlled, blinded, pilot study to assess safety and feasibility

评估四氢大麻酚作为阿片类激动剂治疗阿片类药物使用障碍患者的辅助疗法：一项 II 期安慰剂对照、盲法试点研究，以评估安全性和可行性

• 批准号: 420760
• 负责人: Milloy Michael-John S
• 金额: $ 20.34万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-03-01 至 2023-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=420760&lang=en
• 关键词: Addiction; Cannabinoids; Clinical Trials; Opioid Use Disorder

Communities across Canada are grappling with the opioid overdose crisis. Sparked by the contamination of the illicit drug supply with fentanyl, the crisis has claimed more than 14,000 lives since 2015, many of them individuals living with opioid use disor

加拿大各地的社区正在努力应对阿片类药物过量危机。由于芬太尼对非法药物供应的污染，自2015年以来，这场危机已造成14，000多人死亡，其中许多人患有阿片类药物使用障碍。